Skip to main navigation Skip to search Skip to main content

A multicenter randomized double blind placebo controlled phase 3 study to evaluate the efficacy and safty of B11B059 in adult participants with active systemic lupus erythematosus receiving background nonbiologic lupus standare of care

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/11/22 → 01/10/26

Funding

  • Biogen MA Incorporated: $41,785.00